MortierS., FaictD., SchalkwijkC.G., LameireN.H., De VrieseA.S.Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.Kidney Int2004; 66: 1257–65.
5.
JohnsonD.W., BrownF.G., ClarkeM., BoudvilleN., EliasT.J., FooM.W.Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.J Am Soc Nephrol2012; 23: 1097–107.
6.
HanS.H., AhnS.V., YunJ.Y., TranaeusA., HanD.S.Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions.Am J Kidney Dis2009; 54: 711–20.
7.
ChoY., JohnsonD.W., BadveS.V., CraigJ.C., StrippoliG.F., WigginsK.J.The impact of neutral-ph peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients.Kidney Int2013; 84(5): 969–79.
8.
VisserC.E., Brouwer-SteenbergenJ.J., BetjesM.G., KoomenG.C., BeelenR.H., KredietR.T.Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients.Nephrol Dial Transplant1995; 10: 64–9.
9.
Ho-dac-PannekeetM.M., HiralallJ.K., StruijkD.G., KredietR.T.Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.Adv Perit Dial1997; 13: 17–22.
10.
YamagataK., TomidaC., KoyamaA.Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19: 131–7.
11.
LaiK.N., LaiK.B., LamC.W., ChanT.M., LiF.K., LeungJ.C.Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis2000; 35: 644–52.
12.
YungS., ColesG.A., WilliamsJ.D., DaviesM.The source and possible significance of hyaluronan in the peritoneal cavity.Kidney Int1994; 46: 527–33.
13.
PeppaM., UribarriJ., CaiW., LuM., VlassaraH.Glycoxidation and inflammation in renal failure patients.Am J Kidney Dis2004; 43: 690–5.
14.
LieuwAfml, van HinsberghV.W., TeerlinkT., BartoR., TwiskJ., StehouwerC.D.Increased levels of n(epsilon)-(carboxymethyl)lysine and n(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.Nephrol Dial Transplant2004; 19: 631–6.
15.
MortierS., FaictD., LameireN.H., De VrieseA.S.Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.Kidney Int2005; 67: 1559–65.
